Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Pulmonology

   News

   Conferences

   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Chest Articles

View articles of another specialty


   
A decrease of the activity of the immune system in alcoholics may be responsible for an increased risk of pneumonia.

Dr. Tamer Fouad, M.D.

Friday 26th May, 2006


New data even short-term exposure to common air pollutants dangerous for people over 65 years of age.

Dr. Tamer Fouad, M.D.

Wednesday 15th March, 2006


Whooping cough vaccine has proved more than 90 percent effective in a national, large-scale clinical study.

Dr. Tamer Fouad, M.D.

Friday 14th October, 2005


Xolair reduced the rate of hospital emergency visits by 44% in patients with inadequately controlled asthma.

Dr. Tamer Fouad, M.D.

Tuesday 16th July, 2005


Patients with asthma were most likely to receive a subsequent diagnosis of GERD within the first year of their diagnosis of asthma.

Dr. Tamer Fouad, M.D.

Friday 15th July, 2005


Researchers at SFVAMC hope their results will lead to an earlier, more sensitive, and more accurate standard test for chronic lung rejection.

Dr. Tamer Fouad, M.D.

Friday, 15th July 2005


Eotaxin and other inflammatory mediators may link obesity to asthma, and targeting adiposity/eotaxin may have benefit in obese asthmatics.

Dr. Tamer Fouad, M.D.

Friday, 15th July, 2005


The FDA approved Xolair?, the first in a new class of asthma therapies that are bioengineered to target IgE.

Dr. Tamer Fouad, M.D.

 Tuesday, 1st July 2003


advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application



search_sm.jpg (55x55 -- 1647 bytes)
 

  Search The Doctors Lounge for more articles.

 

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2012 DoctorsLounge®. All rights reserved.